We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Zika Virus Proteins Linked to Fetal Microcephaly through Activation of Autophagy Pathway

By LabMedica International staff writers
Posted on 24 Aug 2016
Two Zika virus (ZIKV) proteins have been implicated in causing microcephaly by inhibiting a molecular pathway required for normal fetal brain development.

The current widespread outbreak of ZIKV infection has been linked to severe clinical birth defects, particularly microcephaly, warranting urgent study of the molecular mechanisms underlying ZIKV pathogenesis.

To this end, investigators at the University of Southern California (Los Angeles, USA) examined the ability of each of the 10 ZIKV proteins collected from three strains of the virus growing in second trimester human fetal neural stem cells (fNSCs) to inhibit the Akt-mTOR molecular pathway. More...
Akt-mTOR signaling is one of the key cellular pathways essential for brain development and autophagy regulation.

Autophagy is a self-degradative cellular process that is important for balancing sources of energy at critical times in development and in response to nutrient stress. Autophagy also plays a housekeeping role in removing misfolded or aggregated proteins, clearing damaged organelles, such as mitochondria, endoplasmic reticulum and peroxisomes, as well as eliminating intracellular pathogens. Thus, autophagy is generally thought of as a survival mechanism, although its deregulation has been linked to non-apoptotic cell death. Autophagy can be either non-selective or selective in the removal of specific organelles, ribosomes, and protein aggregates, although the mechanisms regulating aspects of selective autophagy are not fully understood.

The investigators reported in the August 11, 2016, online edition of the journal Cell Stem Cell that ZIKV infection of human fNSCs caused inhibition of the Akt-mTOR pathway, leading to defective neurogenesis and aberrant activation of autophagy. By screening the three structural proteins and seven nonstructural proteins present in ZIKV, they found that two, NS4A and NS4B, cooperatively suppressed the Akt-mTOR pathway and led to cellular dysregulation.

The action of the two proteins depressed the growth of fNSCs by 65% while reducing differentiation of neural stem cells into mature brain cells, such as neurons and astrocytes, by up to 51%. Corresponding proteins from the closely related dengue virus did not have the same effect on neurogenesis.

“Zika loves and needs autophagy,” said senior author Dr. Jae Jung, professor of molecular microbiology and immunology at the University of Southern California. “Zika raises the activity in this recycling factory so they can use the energy and nutrients there to replicate. It is possible that since Zika is using most of the energy, the neuronal stem cells are left with metabolic deficits. Thus, the chances for them to differentiate and mature into neurons and other brain cell types are much lower.”

“We now know the molecular pathway, so we made the first big step toward target therapy for Zika-induced microcephaly,” said Dr. Jung. “Years from now, one shot or a series of shots could target the proteins NS4A and NS4B or their collaborators.”

Related Links:
University of Southern California


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Drug Test Kit
DrugCheck 3000
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.